Document is current
Any future updates will be listed below
-
Authors
Sgalla, Giacomo
Simonetti, Jacopo
Di Bartolomeo, Arianna
Magrì, Tonia
Iovene, Bruno
Pasciuto, Giuliana
Dell’Ariccia, Ruben
Varone, Francesco
Comes, Alessia
Leone, Paolo Maria
Piluso, Venere
Perrotta, Alessandro
Cicchetti, Giuseppe
Verdirosi, Diana
Richeldi, Luca
- License Information
-
More Information
Article History
Received: 4 August 2024
Accepted: 16 September 2024
First Online: 28 September 2024
Declarations
:
: This study obtained ethics approval from the Fondazione Policlinico Universitario “A. Gemelli” IRCCS review board, Prot. 21807/18 (29798/18), ID: 2104.
: Not applicable.
: GS reports personal fees from Chiesi Farmaceutici, personal fees from Boehringer Ingelheim, outside the submitted work; JS reports personal fees from Chiesi Farmaceutici, personal fees from Boehringer Ingelheim, outside the submitted work; LR reports personal fees from Biogen, grants and personal fees from Roche, personal fees from ImmuneWorks, grants and personal fees from Boehringer Ingelheim, personal fees from Celgene, personal fees from Nitto, personal fees from FibroGen, personal fees from Promedior, personal fees from Pliant Therapeutics, personal fees from Asahi Kasei, personal fees from Toray, personal fees from BMS, personal fees from RespiVant, personal fees from CSL Behring, outside the submitted work; ADB, TM, BI, GP, RDA, FV, AC, PML, AP, GC, DV have no conflicts of interest to disclose.
